As per MRFR analysis, the Surgical Sutures Market Size was estimated at 4.3 (USD Billion) in 2024. The Surgical Sutures Market Industry is expected to grow from 4.51 (USD Billion) in 2025 to 6.94 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.90% during the forecast period (2025 - 2034).
The growth in patients with chronic diseases being admitted to hospitals, the favorable reimbursement environment, and the rise in trauma cases, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Unilene, a prominent producer of surgical sutures, has been engaging in significant medical exhibitions to display its offerings and establish new collaborations. In June 2023, Unilene participated in the FIME 2023 exhibition held in Miami, Florida, where they interacted with industry professionals and investigated potential collaborations. Furthermore, the organization took part in the Omnia Health Live Americas event in November 2023, thereby enhancing its connections within the medical community.
Ethicon, a division of Johnson & Johnson, remains a key contributor to the surgical sutures market. In September 2024, Ethicon transitioned to operating under the name Johnson & Johnson MedTech, streamlining its brand identity within the parent company's MedTech division. The rebranding showcases Ethicon's dedication to progressing surgical technologies and improving patient care with cutting-edge products and solutions.
The number of patients with chronic diseases being admitted to hospitals has increased, as have the number of trauma cases. As many orthopedic, alimentary, ophthalmic, and other instances necessitate surgical suturing in case of surgeries, it is projected that this will raise demand for usage and adoption of surgical sutures. As a result, an increase in operations affected the demand for surgical sutures and favorably impacted the market's expansion.
According to 2019 statistics from the Behavioral Risk Factor Surveillance System (BRFSS), the adult obesity rates in the United States exceeded 35% in nine states, 30% in 31 states, and 25% in 48 states. The same source indicates that Colorado had the lowest adult obesity rate (23%), while Mississippi and West Virginia had the highest percentage (39.5%). The prevalence of obesity in the population is growing, which is driving up demand for bariatric procedures. This fuels the demand for additional surgical sutures to be used in bariatric procedures and helps the market expand more quickly. During the projected period, a number of hospitals and ambulatory surgery centers with specialized and cutting-edge surgical suture procedures may contribute to the market expansion.
As more surgeries are done on patients, there is a growing demand for surgical sutures in the medical field. Improvements in treatment methods are being created as a result of developments in the healthcare sector, which is anticipated to accelerate market expansion. The demand for surgical sutures that are practical for both surgeons and patients is expanding as more and more advanced treatment techniques are being used in operations, notably in countries like the United Kingdom, Germany, the United States, Canada, and Japan.
Additionally, it is anticipated that the aging population would spur market expansion. The industry is expected to develop as a result of the increase in deadly car accidents. The market for surgical sutures would have slower expansion due to other important factors including rising urbanization and rising disposable income. The market for surgical sutures will increase at a faster rate due to good reimbursement conditions and rising healthcare infrastructure spending. Thus, driving the Surgical Sutures market revenue.
The Market segments of Surgical Sutures, based on Type, includes absorbable and non-absorbable. Due to its capacity to offer temporary support to wounds while they heal and can withstand normal tension, absorbable segment led the worldwide market of surgical sutures in 2022. The capacity of absorbable sutures to spontaneously disintegrate can also be seen in the steadily growing demand for them. As a result, major market participants are spending money on R&D projects, which will likely contribute to the future expansion of the absorbable industry.
The Surgical Sutures Market segmentation, based on Filament, includes monofilament and multifilament. During the anticipated period, the multifilament category is anticipated to increase at the quickest rate. This is explained by the multifilament segment's benefits, including improved pliability, high tensile strength, and flexibility.
The market segmentation of Surgical Sutures, based on Application, includes ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, and others. In 2022, the segment that performed cardiovascular surgery had the highest revenue share. This is because cardiac disorders are prevalent, there are enough experts in the field, favorable reimbursement policies, and improvements in diagnostic technology. Due to this, there are now significantly more cardiac operations being performed, which will raise demand for surgical sutures over the projection period.
Figure 1: Surgical Sutures Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Surgical Sutures Market dominated the global market in 2022 with 45.80% share, due to the existence of local and important actors, the high cost of sutures relative to other countries, the favorable reimbursement environment, the growth of government programs, and the developed healthcare infrastructure. The significant revenue share of North America is also largely due to technological improvements and strong domestic wealth. Further, the U.S. market of Surgical Sutures held the largest market share, and the Canada market of Surgical Sutures was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: SURGICAL SUTURES MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Surgical Sutures market accounted for the significant market share in 2022. This can be linked to the aging population's role in the rise in chronic illnesses, which prompt operations and, in turn, raise the need for surgical sutures. The market in the area is anticipated to develop as a result. Further, the German market of Surgical Sutures held the largest market share, and the U.K market of Surgical Sutures was the fastest growing market in the European region
The Asia Pacific Surgical Sutures market is expected to register fastest CAGR from 2023 to 2032. This is because there are more elderly people, who are more prone to need surgery, and because the government is spending more money on the healthcare system to address the unmet needs in this area. Among the important markets in the Asia Pacific region are China, India, and Japan. Another significant driver propelling the market in this area toward exponential growth is the rise of medical tourism in nations like India, Singapore, and Malaysia. Moreover, China’s market of Surgical Sutures held the largest market share, and the Indian market of Surgical Sutures was the fastest growing market in the Asia-Pacific region.
Surgical Sutures Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the market of Surgical Sutures, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Surgical Sutures industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Surgical Sutures industry to benefit clients and increase the market sector. In recent years, the Surgical Sutures industry has offered some of the most significant advantages to medicine. Major players in the market of Surgical Sutures, including Covidien, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica, CONMED CORPORATION, and Sutures India Pvt. Ltd., are attempting to increase market demand by investing in research and development operations.
A division of Johnson & Johnson, Ethicon U.S. LLC (Ethicon) is a manufacturer of medical equipment that does business as Ethicon Inc. and Ethicon Endo-Surgery Inc. It creates and sells surgical gadgets and instruments. Staplers, energy devices, clip appliers, trocars, hemostats, endocutters, suturing devices, endoscopic instruments, electrosurgical and irrigation products, meshes, and allografts are some of the company's main offerings. Its products are utilized in both open and minimally invasive surgeries to treat obesity, colorectal, thoracic, and hernias, as well as cancer. Advanced bipolar energy devices and ultrasonic energy devices are also available from Ethicon. The company has production, sales, and surgical education sites across the Americas, Europe, and Asia-Pacific. The U.S. city of Cincinnati, Ohio, is home to Ethicon. Ethicon US, LLC announced the arrival of the ProxiSureTM Suturing Device in the United States in August 2021.
The development, production, and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT, and advanced wound treatment are the main business activities of Smith & Nephew Plc (Smith & Nephew). The business provides robotics-assisted technologies, knee and hip implants to replace sick, worn, or damaged joints, trauma-related items to support fractures, and deformity repair operations. Additionally, it provides items for treating wounds as well as tools and materials for removing and repairing soft tissue. Surgeons, nurses, nurse specialists, doctors, general practitioners, buying staff at hospitals, and health insurers are among the groups to which Smith & Nephew makes its goods available. The company sells its goods across Africa, the Middle East, Asia-Pacific, Europe, and North America. The UK's Hertfordshire county of Watford is home to Smith & Nephew's headquarters. Smith & Nephew (UK) introduced the NOVOSTITCH PRO Meniscal Repair System, an automated suturing device, in September 2020.
Key Companies in the market of Surgical Sutures include
Surgical Sutures Industry Developments
On January 23, 2024, TPG, a prominent global alternative asset management firm, revealed a noteworthy strategic investment in Compass Surgical Partners, an independent full-service ambulatory surgery center (ASC) development and management partner. This investment seeks to enhance growth and expand capacity to meet the rising demand in ASC joint ventures from health system partners.
In September 2023, Enovis, a global leader in medical technology, revealed its decision to acquire LimaCorporate, an Italian firm renowned for its expertise in joint implants, extremities, and fixation devices. The acquisition, with an estimated value of around €800 million, was finalized on January 3, 2024. This action is anticipated to strengthen Enovis's offerings in the orthopedic field.
In February 2022, Smith & Nephew, a prominent player in the medical technology sector, revealed that Roland Diggelmann would be resigning from his position as CEO. Dr. Deepak Nath has taken over the role, indicating a significant change in the company's leadership strategy.
In January 2021, Smith & Nephew completed the acquisition of the extremity orthopedics division from Integra LifeSciences for a total of $240 million. The purpose of this acquisition was to enhance Smith & Nephew's standing in the extremities market, especially concerning joint reconstruction and trauma.
Surgical Sutures Market Segmentation
Surgical Sutures Type Outlook
Surgical Sutures Filament Outlook
Surgical Sutures Application Outlook
Surgical Sutures Regional Outlook
| Report Attribute/Metric | Details |
| Market Size 2024 | Â Â 4.30 (USD Billion) |
| Market Size 2025 | Â Â 4.51 (USD Billion) |
| Market Size 2034 | Â Â 6.94 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | Â Â 4.90 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Filament, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Covidien, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica, CONMED CORPORATION, and Sutures India Pvt. Ltd. |
| Key Market Opportunities | Technological advancements in suture design |
| Key Market Dynamics | The rise in the hospital admission of chronic disease patients, favorable reimbursement scenario, and increased trauma cases |
Surgical Sutures Market Highlights:
Frequently Asked Questions (FAQ) :
The Surgical Sutures Market size was valued at USD 3.9 Billion in 2022.
The global market is projected to grow at a CAGR of 4.90% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Covidien, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica, CONMED CORPORATION, and Sutures India Pvt. Ltd.
The absorbable category dominated the market in 2022.
The multifilament category had the largest share in the global market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
